Are we ready to escalate or de-escalate immune treatment strategies in NSCLC based on liquid biopsy data?

Jordi Remon, Alvaro Lopez, David Planchard, Benjamin Besse

Résultats de recherche: Contribution à un journal › Editorial

langue originale	Anglais
Numéro d'article	113369
journal	European Journal of Cancer
Volume	195
Les DOIs	https://doi.org/10.1016/j.ejca.2023.113369
état	Publié - 1 déc. 2023

Accès au document

10.1016/j.ejca.2023.113369

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{c93010e2d6be4c6e8d0647812b091cb8,

title = "Are we ready to escalate or de-escalate immune treatment strategies in NSCLC based on liquid biopsy data?",

keywords = "Ct-DNA, Immune checkpoint blockers, Liquid biopsy, Non-small cell lung cancer",

author = "Jordi Remon and Alvaro Lopez and David Planchard and Benjamin Besse",

year = "2023",

month = dec,

day = "1",

doi = "10.1016/j.ejca.2023.113369",

language = "English",

volume = "195",

journal = "European Journal of Cancer",

issn = "0959-8049",

}

TY - JOUR

T1 - Are we ready to escalate or de-escalate immune treatment strategies in NSCLC based on liquid biopsy data?

AU - Remon, Jordi

AU - Lopez, Alvaro

AU - Planchard, David

AU - Besse, Benjamin

PY - 2023/12/1

Y1 - 2023/12/1

KW - Ct-DNA

KW - Immune checkpoint blockers

KW - Liquid biopsy

KW - Non-small cell lung cancer

UR - http://www.scopus.com/inward/record.url?scp=85175263169&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2023.113369

DO - 10.1016/j.ejca.2023.113369

M3 - Editorial

AN - SCOPUS:85175263169

SN - 0959-8049

VL - 195

JO - European Journal of Cancer

JF - European Journal of Cancer

M1 - 113369

ER -